Related articles

• Randomized Controlled Trial

  One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.

  Am J Cardiovasc Drugs. 2012 Apr 1;12(2):117-25.

• Randomized Controlled Trial

  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

  J. Am. Coll. Cardiol. 2014 Jan 7;63(1):62-70.

• Randomized Controlled Trial

  Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

  Clin Ther. 2004 Nov 1;26(11):1821-33.

Show more related articles...